Review the current PDS Biotechnology Corp (PDSB:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if PDSB is the best investment for you.

LONDON, June 30, 2025 (GLOBE NEWSWIRE) -- Portal Biotech, a pioneering biotechnology company headquartered in London, today announced a $35 million Series A raise, representing one of Europe's largest ...

Feature Published: December 1999 The new antibiotics Holger Breithaupt Nature Biotechnology 17, 1165–1169 (1999) Cite this article ...